♥

Nath Bio-Genes (India) Limited

ISIN : INE448G01010
NSE : NATHBIOGEN
BSE : 537291
Face Value : 10
Industry : Agriculture

EPS : 21.34
EPS (TTM) : 21.91
Price to Earning (P/E) : 6.83
Book Value : 320.94
Price to Bookvalue (P/B) : 0.45
Dividend Yield : 1 %
Return on Equity (ROE) : 6.70 %
Return on Capital Employed (ROCE) : 7.26 %

Nath Bio-Genes share price (02-Apr-2026)
National Stock Exchange NSE
Open / Close	0 - 0 NAN %
Low / High	0 - 0 NAN %
Trade Volume	0
52 Week Low / High	0 - 0 NAN %
Bombay Stock Exchange BSE
Open / Close	135 - 139.7 3.5 %
Low / High	134.2 - 140 4.3 %
Trade Volume	1,029
52 Week Low / High	126.75 - 238 87.8 %

YOU MAY ALSO LIKE

Stock market course tutorial
Stock Market Investment Course explained in simple words.
Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE
How much money do you need to retire
Know how much money do you need to retire, before how much to invest ?
High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE
CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
Share Market basics for beginners
Share Market jargons in simple terms

Consolidated Standalone

CONSOLIDATED QUARTERLY RESULT FOR NATH BIO-GENES (INDIA) LIMITED

Date End	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	months	months	months
Net Sales	449.88	2352.81	225.68	317.38	430.38	2438.75	321.93
Total Income	452.44	2353.98	226.3	317.75	434.49	2440.05	322.69
Total Expenditure	410.53	1984.73	170.53	260.92	391.1	2073.4	273.8
Other Income	2.56	1.17	0.62	0.37	4.11	1.3	0.76
Operating Profit	41.91	369.25	55.77	56.83	43.39	366.65	48.89
Interest	15.32	27.64	24.36	28.37	10.73	22.41	29.78
Exceptional Items				25
PBDT	26.59	341.61	31.41	53.46	32.66	344.24	19.11
Depreciation	9.9	7.6	7.6	7.6	9.81	8.25	8.25
Profit Before Tax	16.69	334.01	23.81	45.86	22.85	335.99	10.86
Tax	2.31	2.2	3.45	7.67	6.15	2.45	-0.28
Profit After Tax	14.38	331.81	20.36	38.19	16.7	333.54	11.14
Other Adjustments					9.49
Net Profit	14.38	331.81	20.36	38.19	26.19	333.54	11.14
Equity Capital	190.04	190.04	190.04	190.04	190.04	190.04	190.04
Face Value (IN RS)	10	10	10	10	10	10	10
Reserves	5619.48	5873.72	5850.82	5889.3	5909.15
Calculated EPS	0.76	17.47	1.07	2.01	1.38	17.55	0.59
Diluted Eps After Extraordinary Items	0.76	17.47	0.86	2.02	1.87	17.49	0.53
Diluted Eps Before Extraordinary Items	0.76	17.47	0.86	2.02	1.87	17.49	0.53

STANDALONE QUARTERLY RESULT FOR NATH BIO-GENES (INDIA) LIMITED

Date End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
No of months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months	3 months
Net Sales	2093.9	217.29	252.97	449.15	2352.82	225.68	317.38	430.38	2438.75	321.93
Total Income	2093.9	219.28	253.55	451.78	2353.99	226.3	317.75	434.76	2440.14	322.59
Total Expenditure	1749.1	169.75	196.82	408.34	1982.52	170.53	259.54	385.58	2068.16	256.3
Other Income		1.99	0.58	2.63	1.17	0.62	0.37	4.38	1.39	0.66
Operating Profit	344.8	49.53	56.73	43.44	371.47	55.77	58.21	49.18	371.98	66.29
Interest	28.83	27.51	29.55	15.32	27.65	24.36	28.37	10.63	22.41	29.42
Exceptional Items							25
PBDT	315.97	22.02	27.18	28.12	343.82	31.41	54.84	38.55	349.57	36.87
Depreciation	6.74	6.74	6.74	9.9	7.6	7.6	7.6	9.81	8.25	8.25
Profit Before Tax	309.23	15.28	20.44	18.22	336.22	23.81	47.24	28.74	341.32	28.62
Tax	1.67	0.6	6.95	2.3	2.2	3.45	7.66	6.15	2.45	-0.28
Profit After Tax	307.56	14.68	13.49	15.92	334.02	20.36	39.58	22.59	338.87	28.9
Other Adjustments								9.49
Net Profit	307.56	14.68	13.49	15.92	334.02	20.36	39.58	32.08	338.87	28.9
Equity Capital	190.04	190.04	190.04	190.04	190.04	190.04	190.04	190.04	190.04	190.04
Face Value (IN RS)	10	10	10	10	10	10	10	10	10	10
Reserves	5576.93	5591.63	5605.11	5621.02	5877.53	5855.61	5895.34	5916.54
Calculated EPS	16.18	0.77	0.71	0.84	17.58	1.07	2.08	1.19	17.83	1.52
Diluted Eps After Extraordinary Items	16.18	0.77	0.71	0.84	17.58	0.85	2.09	2.18	17.77	1.46
Diluted Eps Before Extraordinary Items	16.18	0.77	0.71	0.84	17.58	0.85	2.09	2.18	17.77	1.46

Consolidated Standalone

CONSOLIDATED ANNUAL RESULT FOR NATH BIO-GENES (INDIA) LIMITED

Date End	Mar 2023	Mar 2024
No of months	12 months	12 months	months
Net Sales	3013.64	3326.25
Total Income	3019.18	3332.52
Total Expenditure	2526.21	2827.63
Other Income	5.54	6.27
Operating Profit	492.97	504.89
Interest	101.21	91.11
PBDT	391.76	413.78
Depreciation	30.12	32.61
Profit Before Tax	361.64	381.17
Tax	11.52	19.46
Profit After Tax	350.12	361.71
Other Adjustments		34.49
Net Profit	350.12	396.2
Equity Capital	190.04	190.04
Face Value (IN RS)	10	10
Reserves	5619.48	5909.15
Calculated EPS	18.42	20.85
Diluted Eps After Extraordinary Items	18.42	21.34
Diluted Eps Before Extraordinary Items	18.42	21.34

STANDALONE ANNUAL RESULT FOR NATH BIO-GENES (INDIA) LIMITED

Date End	Mar 2022	Mar 2023	Mar 2024
No of months	12 months	12 months	12 months
Net Sales	2802.17	3012.92	3326.25
Total Income	2802.17	3018.52	3332.78
Total Expenditure	2411.26	2524.02	2822.41
Other Income		5.6	6.53
Operating Profit	390.91	494.5	510.37
Interest	106.11	101.21	91.02
Exceptional Items	-887.82
PBDT	-603.02	393.29	419.35
Depreciation	30.84	30.12	32.61
Profit Before Tax	-633.86	363.17	386.74
Tax	39.51	11.52	19.46
Profit After Tax	-673.37	351.65	367.28
Other Adjustments			34.49
Net Profit	-673.37	351.65	401.77
Equity Capital	190.04	190.04	190.04
Face Value (IN RS)	10	10	10
Reserves	5269.37	5621.02	5916.54
Calculated EPS	-35.43	18.5	19.33
Diluted Eps After Extraordinary Items	-35.43	18.5	21.63
Diluted Eps Before Extraordinary Items	-35.43	18.5	21.63

Consolidated Standalone

CONSOLIDATED PROFIT / LOSS FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	months
Gross Sales	278.36 Cr	301.36 Cr	332.62 Cr	0
Sales	277.29 Cr	300.2 Cr	331.23 Cr	0
Net Sales	278.36 Cr	301.36 Cr	332.62 Cr	0
Increase/Decrease in Stock	4.99 Cr	11.98 Cr	-21.16 Cr	0
Raw Material Consumed	3.56 Cr	5.31 Cr	12.26 Cr	0
Other Direct Purchases / Brought in cost	3.56 Cr	5.31 Cr	12.26 Cr	0
Power & Fuel Cost	1.07 Cr	1.39 Cr	1.13 Cr	0
Electricity & Power	1.07 Cr	1.39 Cr	1.13 Cr	0
Employee Cost	24.78 Cr	23.32 Cr	27.58 Cr	0
Salaries, Wages & Bonus	23.41 Cr	21.63 Cr	25.73 Cr	0
Contributions to EPF & Pension Funds	1.08 Cr	1.11 Cr	1.24 Cr	0
Workmen and Staff Welfare Expenses	28.69 Lk	57.55 Lk	60.66 Lk	0
Other Manufacturing Expenses	127.95 Cr	110.61 Cr	138.3 Cr	0
Processing Charges	90.43 Cr	69.83 Cr	99.49 Cr	0
Repairs and Maintenance	87.79 Lk	1.31 Cr	1.09 Cr	0
General and Administration Expenses	18 Cr	18.3 Cr	21.74 Cr	0
Rent , Rates & Taxes	3.28 Cr	3.18 Cr	3.58 Cr	0
Insurance	47.44 Lk	43.61 Lk	48.72 Lk	0
Printing and stationery	20.93 Lk	20.05 Lk	22.5 Lk	0
Professional and legal fees	3.75 Cr	2.75 Cr	4.31 Cr	0
Traveling and conveyance	3.52 Cr	4.81 Cr	4.76 Cr	0
Selling and Distribution Expenses	58.9 Cr	80.19 Cr	101.16 Cr	0
Advertisement & Sales Promotion	1.63 Cr	3.7 Cr	5.05 Cr	0
Sales Commissions & Incentives	5.56 Lk	0	0	0
Freight and Forwarding	8.15 Cr	8.41 Cr	10.37 Cr	0
Miscellaneous Expenses	1.89 Cr	1.43 Cr	1.65 Cr	0
Bad debts /advances written off	44.98 Lk	11.72 Lk	24.02 Lk	0
Loss on disposal of fixed assets(net)	5,000	20,000	51,000	0
Loss on foreign exchange fluctuations	0	0	1.36 Lk	0
Total Expenditure	241.14 Cr	252.53 Cr	282.67 Cr	0
Other Income	1.85 Cr	55.35 Lk	62.66 Lk	0
Interest Received	1.09 Cr	1.79 Lk	32.24 Lk	0
Dividend Received	6,000	3,000	3,000	0
Profit on sale of Fixed Assets	41,000	8,000	61,000	0
Provision Written Back	46.42 Lk	0	0	0
Foreign Exchange Gains	5.86 Lk	42.95 Lk	0	0
Operating Profit	39.08 Cr	49.39 Cr	50.58 Cr	0
Interest	10.64 Cr	10.21 Cr	9.2 Cr	0
Interest on Term Loan	1.53 Cr	76 Lk	46.19 Lk	0
Intereston Fixed deposits	33.96 Lk	32.22 Lk	39.17 Lk	0
Bank Charges etc	51.85 Lk	78.54 Lk	57.61 Lk	0
PBDT	28.43 Cr	39.18 Cr	41.38 Cr	0
Depreciation	3.08 Cr	3.01 Cr	3.26 Cr	0
Profit Before Taxation & Exceptional Items	25.35 Cr	36.16 Cr	38.12 Cr	0
Exceptional Income / Expenses	-88.78 Cr	0	3.45 Cr	0
Profit Before Tax	-63.43 Cr	36.16 Cr	41.56 Cr	0
Provision for Tax	3.95 Cr	1.15 Cr	1.95 Cr	0
Current Income Tax	2.34 Cr	1.19 Cr	1.92 Cr	0
Profit After Tax	-67.39 Cr	35.01 Cr	39.62 Cr	0
Minority Interest	47,000	1.53 Lk	0	0
Consolidated Net Profit	-67.38 Cr	35.03 Cr	39.62 Cr	0
Profit Balance B/F	445.61 Cr	374.43 Cr	405.66 Cr	0
Appropriations	378.23 Cr	409.46 Cr	445.28 Cr	0
Other Appropriation	3.8 Cr	3.8 Cr	3.8 Cr	0
Equity Dividend %	20	20	20
Earnings Per Share	-35.46	18.43	20.85
Adjusted EPS	-35.46	18.43	20.85

STANDALONE PROFIT / LOSS FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Gross Sales	307.56 Cr	278.36 Cr	301.29 Cr	332.62 Cr
Sales	305.76 Cr	277.29 Cr	300.12 Cr	331.23 Cr
Net Sales	307.56 Cr	278.36 Cr	301.29 Cr	332.62 Cr
Increase/Decrease in Stock	-21.76 Cr	4.99 Cr	11.98 Cr	-19.92 Cr
Raw Material Consumed	8.96 Cr	3.56 Cr	5.31 Cr	11.02 Cr
Other Direct Purchases / Brought in cost	8.96 Cr	3.56 Cr	5.31 Cr	11.02 Cr
Power & Fuel Cost	1.23 Cr	1.07 Cr	1.39 Cr	1.13 Cr
Electricity & Power	1.23 Cr	1.07 Cr	1.39 Cr	1.13 Cr
Employee Cost	23.69 Cr	24.78 Cr	23.23 Cr	27.31 Cr
Salaries, Wages & Bonus	22.43 Cr	23.41 Cr	21.54 Cr	25.47 Cr
Contributions to EPF & Pension Funds	1.02 Cr	1.08 Cr	1.11 Cr	1.24 Cr
Workmen and Staff Welfare Expenses	23.45 Lk	28.69 Lk	57.54 Lk	60.12 Lk
Other Manufacturing Expenses	161.23 Cr	127.95 Cr	110.59 Cr	138.29 Cr
Processing Charges	116.59 Cr	90.43 Cr	69.81 Cr	99.49 Cr
Repairs and Maintenance	1.08 Cr	87.79 Lk	1.31 Cr	1.09 Cr
General and Administration Expenses	17.92 Cr	17.95 Cr	18.21 Cr	21.52 Cr
Rent , Rates & Taxes	3.34 Cr	3.27 Cr	3.13 Cr	3.55 Cr
Insurance	40.66 Lk	47.44 Lk	43.61 Lk	48.72 Lk
Printing and stationery	16.5 Lk	20.93 Lk	20.04 Lk	22.49 Lk
Professional and legal fees	2.55 Cr	3.71 Cr	2.75 Cr	4.31 Cr
Traveling and conveyance	3.09 Cr	3.52 Cr	4.77 Cr	4.56 Cr
Selling and Distribution Expenses	47.77 Cr	58.9 Cr	80.17 Cr	101.16 Cr
Advertisement & Sales Promotion	1.94 Cr	1.63 Cr	3.7 Cr	5.05 Cr
Sales Commissions & Incentives	1.26 Lk	5.56 Lk	0	0
Freight and Forwarding	8.09 Cr	8.15 Cr	8.39 Cr	10.37 Cr
Miscellaneous Expenses	1.75 Cr	1.89 Cr	1.42 Cr	1.64 Cr
Bad debts /advances written off	33.71 Lk	44.98 Lk	11.72 Lk	24.02 Lk
Loss on disposal of fixed assets(net)	1.38 Lk	5,000	20,000	51,000
Loss on foreign exchange fluctuations	12.33 Lk	0	0	0
Total Expenditure	240.8 Cr	241.09 Cr	252.31 Cr	282.15 Cr
Other Income	1.67 Cr	1.85 Cr	56.04 Lk	65.34 Lk
Interest Received	1.21 Cr	1.09 Cr	2.07 Lk	32.24 Lk
Dividend Received	0	6,000	3,000	3,000
Profit on sale of Fixed Assets	1.79 Lk	41,000	8,000	61,000
Provision Written Back	30.03 Lk	46.42 Lk	0	0
Foreign Exchange Gains	0	5.91 Lk	43.37 Lk	2.68 Lk
Operating Profit	68.43 Cr	39.12 Cr	49.54 Cr	51.13 Cr
Interest	8.87 Cr	10.64 Cr	10.21 Cr	9.19 Cr
Interest on Term Loan	0	0	76 Lk	45.26 Lk
Intereston Fixed deposits	0	0	32.22 Lk	39.17 Lk
Bank Charges etc	96.38 Lk	51.85 Lk	78.46 Lk	57.4 Lk
PBDT	59.57 Cr	28.48 Cr	39.33 Cr	41.94 Cr
Depreciation	2.82 Cr	3.08 Cr	3.01 Cr	3.26 Cr
Profit Before Taxation & Exceptional Items	56.75 Cr	25.4 Cr	36.32 Cr	38.67 Cr
Exceptional Income / Expenses	0	-88.78 Cr	0	3.45 Cr
Profit Before Tax	56.75 Cr	-63.39 Cr	36.32 Cr	42.12 Cr
Provision for Tax	1.09 Cr	3.95 Cr	1.15 Cr	1.95 Cr
Current Income Tax	18.86 Lk	2.34 Cr	1.19 Cr	1.92 Cr
Deferred Tax	69.37 Lk	0	0	0
Profit After Tax	55.66 Cr	-67.34 Cr	35.17 Cr	40.18 Cr
Consolidated Net Profit	55.66 Cr	-67.34 Cr	35.17 Cr	40.18 Cr
Profit Balance B/F	389.95 Cr	445.61 Cr	374.47 Cr	405.84 Cr
Appropriations	445.61 Cr	378.27 Cr	409.64 Cr	446.02 Cr
Other Appropriation	0	3.8 Cr	3.8 Cr	3.8 Cr
Equity Dividend %	20	20	20	20
Earnings Per Share	29.29	-35.43	18.5	21.14
Adjusted EPS	29.29	-35.43	18.5	21.14

Consolidated Standalone

CONSOLIDATED CASH FLOW FOR NATH BIO-GENES (INDIA) LIMITED

Year End	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	months
Profit Before Tax	-63.43 Cr	36.16 Cr	41.56 Cr	0
Adjustment	102.29 Cr	12.94 Cr	10.27 Cr	0
Changes In working Capital	-18.93 Cr	-9.81 Cr	23.09 Cr	0
Cash Flow after changes in Working Capital	19.93 Cr	39.29 Cr	74.93 Cr	0
Cash Flow from Operating Activities	17.05 Cr	38.37 Cr	74.59 Cr	0
Cash Flow from Investing Activities	-19.85 Cr	-2.88 Cr	-27.4 Cr	0
Cash Flow from Financing Activitie	-22.23 Cr	-1.67 Cr	-7.78 Cr	0
Net Cash Inflow / Outflow	-25.04 Cr	33.81 Cr	39.41 Cr	0
Opening Cash & Cash Equivalents	29.22 Cr	4.18 Cr	38 Cr	0
Closing Cash & Cash Equivalent	4.18 Cr	38 Cr	77.41 Cr	0

STANDALONE CASH FLOW FOR NATH BIO-GENES (INDIA) LIMITED

Year End	Mar 2021	Mar 2022	Mar 2023	Mar 2024
No of Months	12 months	12 months	12 months	12 months
Profit Before Tax	56.75 Cr	-63.39 Cr	36.32 Cr	42.12 Cr
Adjustment	9.79 Cr	101.38 Cr	12.93 Cr	10.27 Cr
Changes In working Capital	-65.13 Cr	-18.07 Cr	-9.97 Cr	22.67 Cr
Cash Flow after changes in Working Capital	1.42 Cr	19.92 Cr	39.29 Cr	75.06 Cr
Cash Flow from Operating Activities	1.11 Cr	17.05 Cr	38.37 Cr	74.72 Cr
Cash Flow from Investing Activities	-10.28 Cr	-19.87 Cr	-2.88 Cr	-27.4 Cr
Cash Flow from Financing Activitie	16.4 Cr	-22.23 Cr	-1.67 Cr	-9.81 Cr
Net Cash Inflow / Outflow	7.23 Cr	-25.05 Cr	33.82 Cr	37.52 Cr
Opening Cash & Cash Equivalents	21.98 Cr	29.22 Cr	4.17 Cr	37.98 Cr
Closing Cash & Cash Equivalent	29.22 Cr	4.17 Cr	37.98 Cr	75.5 Cr

Consolidated Standalone

CONSOLIDATED BALANCE SHEET FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2022	Mar 2023	Mar 2024
Share Capital	19 Cr	19 Cr	19 Cr	0
Equity - Authorised	20.5 Cr	20.5 Cr	20.5 Cr	0
Equity - Issued	19 Cr	19 Cr	19 Cr	0
Equity Paid Up	19 Cr	19 Cr	19 Cr	0
Face Value	10	10	10
Total Reserves	522.92 Cr	554.17 Cr	590.92 Cr	0
Securities Premium	133.5 Cr	133.5 Cr	133.5 Cr	0
Capital Reserves	11.72 Cr	11.72 Cr	11.72 Cr	0
Profit & Loss Account Balance	374.43 Cr	405.66 Cr	441.47 Cr	0
General Reserves	2.97 Cr	2.97 Cr	2.97 Cr	0
Reserve excluding Revaluation Reserve	522.92 Cr	554.17 Cr	590.92 Cr	0
Shareholder's Funds	541.93 Cr	573.17 Cr	609.92 Cr	0
Minority Interest	-46,000	-1.97 Lk	0	0
Secured Loans	66.48 Lk	40.32 Lk	2.83 Cr	0
Unsecured Loans	0	0	2.04 Cr	0
Long Term Provisions	2.61 Cr	2.79 Cr	3 Cr	0
Total Non-Current Liabilities	3.28 Cr	3.19 Cr	7.86 Cr	0
Trade Payables	42.78 Cr	27.74 Cr	43.3 Cr	0
Sundry Creditors	42.78 Cr	27.74 Cr	43.3 Cr	0
Other Current Liabilities	57.95 Cr	83.77 Cr	113.19 Cr	0
Advances received from customers	15.81 Cr	14.81 Cr	28.18 Cr	0
Short Term Borrowings	91.58 Cr	104.08 Cr	104.13 Cr	0
Secured ST Loans repayable on Demands	89.7 Cr	103.05 Cr	99.22 Cr	0
Short Term Provisions	1.97 Cr	87.11 Lk	1.83 Cr	0
Provision for Tax	88.74 Lk	28.05 Lk	94.73 Lk	0
Total Current Liabilities	194.29 Cr	216.45 Cr	262.45 Cr	0
Total Liabilities	739.49 Cr	792.8 Cr	880.23 Cr	0
Gross Block	267.3 Cr	269.62 Cr	274.21 Cr	0
Less: Accumulated Depreciation	22.41 Cr	25.25 Cr	24.75 Cr	0
Net Block	244.89 Cr	244.38 Cr	249.46 Cr	0
Non Current Investments	5.05 Cr	5.05 Cr	6.05 Cr	0
Long Term Investment	5.05 Cr	5.05 Cr	6.05 Cr	0
Unquoted	5.05 Cr	5.05 Cr	6.05 Cr	0
Long Term Loans & Advances	21.79 Cr	22.54 Cr	53.06 Cr	0
Total Non-Current Assets	271.72 Cr	271.96 Cr	308.57 Cr	0
Unquoted	5.05 Cr	5.05 Cr	6.05 Cr	0
Inventories	220.34 Cr	207.85 Cr	230.31 Cr	0
Work-in Progress	189.72 Cr	190.8 Cr	211.34 Cr	0
Stores and Spare	6.12 Cr	5.6 Cr	6.91 Cr	0
Sundry Debtors	85.55 Cr	97.31 Cr	94.31 Cr	0
Debtors more than Six months	61.8 Cr	18.34 Cr	54.77 Cr	0
Debtors Others	29.78 Cr	86.82 Cr	46.58 Cr	0
Cash and Bank	4.18 Cr	38 Cr	77.41 Cr	0
Cash in hand	4.75 Lk	3.95 Lk	2.75 Lk	0
Balances at Bank	4.13 Cr	37.96 Cr	77.38 Cr	0
Other Current Assets	39.49 Lk	37.3 Lk	46.46 Lk	0
Interest accrued and or due on loans	4.69 Lk	1.34 Lk	17.42 Lk	0
Prepaid Expenses	34.8 Lk	35.96 Lk	29.04 Lk	0
Short Term Loans and Advances	157.3 Cr	177.3 Cr	169.17 Cr	0
Advances recoverable in cash or in kind	238.93 Cr	259.71 Cr	248.27 Cr	0
Advance income tax and TDS	6.89 Cr	6.05 Cr	5.11 Cr	0
Total Current Assets	467.77 Cr	520.83 Cr	571.66 Cr	0
Net Current Assets (Including Current Investments)	273.48 Cr	304.38 Cr	309.22 Cr	0
Total Assets	739.49 Cr	792.8 Cr	880.23 Cr	0
Contingent Liabilities	60.59 Cr	71.85 Cr	92.4 Cr	0
Total Debt	92.96 Cr	105.21 Cr	110.35 Cr	0
Adjusted Book Value	285.17	301.61	320.94

STANDALONE BALANCE SHEET FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Share Capital	19 Cr	19 Cr	19 Cr	19 Cr
Equity - Authorised	20.5 Cr	20.5 Cr	20.5 Cr	20.5 Cr
Equity - Issued	19 Cr	19 Cr	19 Cr	19 Cr
Equity Paid Up	19 Cr	19 Cr	19 Cr	19 Cr
Face Value	10	10	10	10
Total Reserves	594.28 Cr	522.96 Cr	554.35 Cr	591.65 Cr
Securities Premium	133.5 Cr	133.5 Cr	133.5 Cr	133.5 Cr
Capital Reserves	11.72 Cr	11.72 Cr	11.72 Cr	11.72 Cr
Profit & Loss Account Balance	445.61 Cr	374.47 Cr	405.84 Cr	442.21 Cr
General Reserves	2.97 Cr	2.97 Cr	2.97 Cr	2.97 Cr
Reserve excluding Revaluation Reserve	594.28 Cr	522.96 Cr	554.35 Cr	591.65 Cr
Shareholder's Funds	613.28 Cr	541.97 Cr	573.35 Cr	610.66 Cr
Secured Loans	65.28 Lk	66.48 Lk	40.32 Lk	2.83 Cr
Long Term Provisions	2.57 Cr	2.61 Cr	2.79 Cr	3 Cr
Total Non-Current Liabilities	3.23 Cr	3.28 Cr	3.19 Cr	5.83 Cr
Trade Payables	45.23 Cr	55.09 Cr	27.74 Cr	42.07 Cr
Sundry Creditors	45.23 Cr	55.09 Cr	27.74 Cr	42.07 Cr
Other Current Liabilities	30.37 Cr	48.02 Cr	83.74 Cr	112.56 Cr
Advances received from customers	4.9 Cr	15.81 Cr	14.81 Cr	28.18 Cr
Short Term Borrowings	94.37 Cr	91.58 Cr	104.08 Cr	104.13 Cr
Secured ST Loans repayable on Demands	86.44 Cr	89.7 Cr	103.05 Cr	99.22 Cr
Short Term Provisions	3.02 Cr	1.97 Cr	87.11 Lk	1.83 Cr
Provision for Tax	2.53 Cr	88.74 Lk	28.05 Lk	94.73 Lk
Total Current Liabilities	173 Cr	196.66 Cr	216.43 Cr	260.6 Cr
Total Liabilities	789.51 Cr	741.91 Cr	792.97 Cr	877.08 Cr
Gross Block	267.28 Cr	267.3 Cr	269.62 Cr	274.2 Cr
Less: Accumulated Depreciation	20.36 Cr	22.41 Cr	25.25 Cr	24.75 Cr
Net Block	246.93 Cr	244.89 Cr	244.38 Cr	249.46 Cr
Non Current Investments	5.05 Cr	5.06 Cr	5.06 Cr	6.06 Cr
Long Term Investment	5.05 Cr	5.06 Cr	5.06 Cr	6.06 Cr
Unquoted	5.05 Cr	5.06 Cr	5.06 Cr	6.06 Cr
Long Term Loans & Advances	13.64 Cr	21.79 Cr	22.54 Cr	53.05 Cr
Total Non-Current Assets	265.62 Cr	271.74 Cr	271.98 Cr	308.56 Cr
Unquoted	5.05 Cr	5.06 Cr	5.06 Cr	6.06 Cr
Inventories	226.3 Cr	220.34 Cr	207.85 Cr	229.07 Cr
Work-in Progress	203.03 Cr	189.72 Cr	190.8 Cr	210.1 Cr
Stores and Spare	7.09 Cr	6.12 Cr	5.6 Cr	6.91 Cr
Sundry Debtors	109.39 Cr	87.92 Cr	97.31 Cr	94.31 Cr
Debtors more than Six months	0	61.8 Cr	18.34 Cr	54.77 Cr
Debtors Others	112.6 Cr	29.78 Cr	86.82 Cr	46.58 Cr
Cash and Bank	29.22 Cr	4.17 Cr	37.98 Cr	75.5 Cr
Cash in hand	3.45 Lk	4.75 Lk	3.64 Lk	2.36 Lk
Balances at Bank	29.18 Cr	4.12 Cr	37.95 Cr	75.48 Cr
Other Current Assets	3.04 Cr	2.98 Cr	37.27 Lk	46.46 Lk
Interest accrued and or due on loans	3.36 Lk	4.69 Lk	1.31 Lk	17.42 Lk
Prepaid Expenses	27.97 Lk	34.8 Lk	35.96 Lk	29.04 Lk
Short Term Loans and Advances	155.94 Cr	154.76 Cr	177.48 Cr	169.17 Cr
Advances recoverable in cash or in kind	155.36 Cr	238.97 Cr	259.88 Cr	248.27 Cr
Advance income tax and TDS	2.78 Cr	6.89 Cr	6.05 Cr	5.11 Cr
Total Current Assets	523.89 Cr	470.17 Cr	520.99 Cr	568.52 Cr
Net Current Assets (Including Current Investments)	350.89 Cr	273.51 Cr	304.56 Cr	307.92 Cr
Total Assets	789.51 Cr	741.91 Cr	792.97 Cr	877.08 Cr
Contingent Liabilities	60.41 Cr	60.65 Cr	71.85 Cr	92.4 Cr
Total Debt	96.57 Cr	92.96 Cr	105.21 Cr	108.31 Cr
Book Value	322.71	285.19	0	0
Adjusted Book Value	322.71	285.19	301.7	321.33

Consolidated Standalone

FINANCIAL RATIOS (CONSOLIDATED) FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	-35.46	18.43	20.85
CEPS(Rs)	-33.84	20.01	22.56
DPS(Rs)	2	2	2
Book NAV/Share(Rs)	285.17	301.61	320.94
Tax Rate(%)	-6.23	3.19	4.68
Margin Ratios
Core EBITDA Margin(%)	13.37	16.21	15.02
EBIT Margin(%)	-18.96	15.39	15.26
Pre Tax Margin(%)	-22.79	12	12.5
PAT Margin (%)	-24.21	11.62	11.91
Cash Profit Margin (%)	-23.1	12.62	12.89
Performance Ratios
ROA(%)	-15.03	4.57	4.74
ROE(%)	-22.48	6.28	6.7
ROCE(%)	-14.84	7.06	7.26
Asset Turnover(x)	0.62	0.39	0.4
Sales/Fixed Asset(x)	1.62	1.12	1.22
Working Capital/Sales(x)	1.02	0.99	1.08
Efficiency Ratios
Fixed Capital/Sales(x)	0.62	0.89	0.82
Receivable days	69.85	110.74	105.14
Inventory Days	195.06	259.3	240.4
Payable days	1503.38	744.29	-1457.17
Valuation Parameters
PER(x)	0	7.69	8.33
PCE(x)	-6.31	7.08	7.7
Price/Book(x)	0.75	0.47	0.54
Yield(%)	0.94	1.41	1.15
EV/Net Sales(x)	1.78	1.12	1.09
EV/Core EBITDA(x)	12.65	6.81	7.18
EV/EBIT(x)	-9.36	7.26	7.15
EV/CE(x)	0.67	0.42	0.5
M Cap / Sales	1.46	0.89	0.99
Growth Ratio
Net Sales Growth(%)	102.15	8.26	10.37
Core EBITDA Growth(%)	90.81	26.4	2.11
EBIT Growth(%)	-430.58	187.85	9.13
PAT Growth(%)	-673.7	151.96	13.16
EPS Growth(%)	-583.11	151.98	13.11
Financial Stability Ratios
Total Debt/Equity(x)	0.17	0.18	0.18
Current Ratio(x)	2.41	2.41	2.18
Quick Ratio(x)	1.27	1.45	1.3
Interest Cover(x)	-4.96	4.54	5.52
Total Debt/Mcap(x)	0.23	0.39	0.33

FINANCIAL RATIOS (STANDALONE) FOR NATH BIO-GENES (INDIA) LIMITED

YEAR	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Operational & Financial Ratios
Earnings Per Share (Rs)	29.29	-35.43	18.5	21.14
CEPS(Rs)	30.77	-33.81	20.09	22.86
DPS(Rs)	2	2	2	2
Book NAV/Share(Rs)	322.71	285.19	301.7	321.33
Tax Rate(%)	1.92	-6.23	3.17	4.62
Margin Ratios
Core EBITDA Margin(%)	21.71	13.39	16.26	15.17
EBIT Margin(%)	21.33	-18.95	15.44	15.43
Pre Tax Margin(%)	18.45	-22.77	12.05	12.66
PAT Margin (%)	18.1	-24.19	11.67	12.08
Cash Profit Margin (%)	19.01	-23.08	12.67	13.06
Performance Ratios
ROA(%)	7.33	-8.79	4.59	4.81
ROE(%)	9.51	-11.66	6.31	6.79
ROCE(%)	9.81	-7.82	7.09	7.34
Asset Turnover(x)	0.41	0.36	0.39	0.4
Sales/Fixed Asset(x)	1.16	1.04	1.12	1.22
Working Capital/Sales(x)	0.88	1.02	0.99	1.08
Efficiency Ratios
Fixed Capital/Sales(x)	0.87	0.96	0.89	0.82
Receivable days	128.4	129.36	110.76	105.14
Inventory Days	255.51	292.83	259.37	239.72
Payable days	91.39	1925.94	744.29	-1432.06
Valuation Parameters
PER(x)	10.24	0	7.66	8.22
PCE(x)	9.75	-6.31	7.05	7.6
Price/Book(x)	0.93	0.75	0.47	0.54
Yield(%)	0.67	0.94	1.41	1.15
EV/Net Sales(x)	2.07	1.78	1.12	1.09
EV/Core EBITDA(x)	9.31	12.63	6.79	7.1
EV/EBIT(x)	9.71	-9.37	7.23	7.07
EV/CE(x)	0.81	0.67	0.42	0.5
M Cap / Sales	1.85	1.46	0.89	0.99
Growth Ratio
Net Sales Growth(%)	9.89	-9.49	8.24	10.4
Core EBITDA Growth(%)	20.87	-42.83	26.63	2.9
EBIT Growth(%)	18.95	-180.38	188.22	9.94
PAT Growth(%)	10.26	-220.98	152.22	14.25
EPS Growth(%)	10.26	-220.98	152.22	14.25
Financial Stability Ratios
Total Debt/Equity(x)	0.16	0.17	0.18	0.18
Current Ratio(x)	3.03	2.39	2.41	2.18
Quick Ratio(x)	1.72	1.27	1.45	1.3
Interest Cover(x)	7.4	-4.96	4.56	5.58
Total Debt/Mcap(x)	0.17	0.23	0.39	0.33

SHARE HOLDING PATTERN FOR NATH BIO-GENES (INDIA) LIMITED

Date	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters %	41.03	41.05	41.07	45.60	45.60	45.60	45.60	45.60	45.60	45.60
FII %	0.04	0.07	0.11	0.01	0.15	0.13	0.22	0.32	0.27	0.21
DII %	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Public %	51.76	54.02	54.20	49.77	49.63	49.65	49.81	49.72	49.76	49.82

PEER COMPARISON FOR NATH BIO-GENES (INDIA) LIMITED

No.	Name
1	Kanel Industries Limited
2	TRANSCHEM LTD
3	Harrisons Malayalam Limited
4	Bombay Burmah Trading Corporation Limited
5	Venky's (India) Limited
6	Kaveri Seed Company Limited
7	Agri-Tech (India) Limited
8	Nath Bio-Genes (India) Limited
9	Bombay Super Hybrid Seeds Limited
10	Mangalam Global Enterprise Limited

CORPORATE ACTIONS FOR NATH BIO-GENES

Exchange Date	Purpose	Book Closure Dates
BSE 17-Oct-2024	Board Meeting - Quarterly Results	23-Oct-2024
BSE 30-Jul-2024	Board Meeting - Quarterly Results	07-Aug-2024
BSE 24-Jul-2024	Book Closure - A.G.M.	13-Aug-2024 17-Aug-2024
BSE 24-Jul-2024	AGM - A.G.M.	17-Aug-2024 17-Aug-2024
BSE 08-May-2024	Dividend - Rs.2.0000 per share(20%)Final Dividend
BSE 30-Apr-2024	Board Meeting - Final Dividend & Audited Results	08-May-2024
BSE 18-Jan-2024	Book Closure - E.G.M.	08-Mar-2024 12-Mar-2024
BSE 09-Jan-2024	Board Meeting - Quarterly Results	18-Jan-2024
BSE 06-Oct-2023	Board Meeting - Quarterly Results	16-Oct-2023
BSE 02-Aug-2023	Board Meeting - Quarterly Results	10-Aug-2023
BSE 23-May-2023	Book Closure - Rs.2.0000 per share(20%)Final Dividend & A.G.M.	05-Jul-2023 11-Jul-2023
BSE 23-May-2023	AGM - Rs.2.0000 per share(20%)Final Dividend & A.G.M.	11-Jul-2023 11-Jul-2023
BSE 25-Apr-2023	Book Closure - Rs.2.0000 per share(20%)Final Dividend & A.G.M.	25-Jun-2023 30-Jun-2023
BSE 24-Apr-2023	Dividend - Rs.2.0000 per share(20%)Final Dividend
BSE 17-Apr-2023	Board Meeting - Final Dividend & Audited Results	22-Apr-2023
BSE 03-Feb-2023	Board Meeting - Quarterly Results	14-Feb-2023
BSE 13-Oct-2022	Board Meeting - Quarterly Results	20-Oct-2022
BSE 08-Aug-2022	Board Meeting - Quarterly Results	13-Aug-2022
BSE 03-Jun-2022	Book Closure - Rs.2.0000 per share(20%)Dividend & A.G.M.	25-Jun-2022 30-Jun-2022
BSE 03-Jun-2022	AGM - Rs.2.0000 per share(20%)Dividend & A.G.M.	30-Jun-2022 30-Jun-2022
BSE 30-May-2022	Dividend - Rs.2.0000 per share(20%)Dividend
BSE 24-May-2022	Board Meeting - Dividend & Audited Results & A.G.M.	30-May-2022
BSE 04-Feb-2022	Board Meeting - Quarterly Results	11-Feb-2022
BSE 25-Oct-2021	Board Meeting - Quarterly Results	01-Nov-2021

CORPORATE ANNOUNCEMENTS FOR NATH BIO-GENES

Exchange Date	Category File	Description
BSE 28-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Earnings Call Transcript Transcript of Conference call held on 24th October 2024.
BSE 28-Oct-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation
BSE 25-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Earnings Call Transcript Audio Transcript of Earning Call held on 24th October 2024
BSE 23-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Presentation on Unaudited financial results as on 30th Sept 2024.
BSE 23-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Change in Management Change in Chief Financial Officer of the Company.
BSE 23-Oct-2024	Outcome FILE	Board Meeting Outcome for Outcome Of Board Meeting Unaudited financial results as on 30th Sept 2024.
BSE 23-Oct-2024	Outcome FILE	Unaudited Financial Results As On 30Th Sept 2024 Outcome of Board Meeting
BSE 19-Oct-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Intimation of conference call to be held on 24th October 2024 at 05:00 PM.
BSE 17-Oct-2024	Intimation FILE	Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Half Year Ended 30Th September 2024. Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/10/2024 inter alia to consider and approve unaudited financial results for the quarter and half year ended 30th September 2024.
BSE 27-Sep-2024	Intimation FILE	Closure of Trading Window Closure of Trading window
BSE 22-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of Loss of Share Certificate of Shareholder
BSE 17-Aug-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report The Annual General Meeting of the Company held today on 17th August 2024 at 11:00 AM.please find the attached 1. Proceedings of Annual General Meeting 2. Voting results 3. Scrutinizers Report for Annual General Meeting
BSE 17-Aug-2024	Outcome FILE	Shareholder Meeting / Postal Ballot-Outcome of AGM Outcome of 31st Annual General Meeting of the Company.
BSE 09-Aug-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of Loss of Share Certificate
BSE 07-Aug-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Presentation on Unaudited Financial results as on 30th June 2024
BSE 07-Aug-2024	Outcome FILE	Unaudited Financial Results As On 30Th June 2024 Outcome of Board Meeting
BSE 07-Aug-2024	Outcome FILE	Board Meeting Outcome for Outcome Of Board Meeting Held On 07Th August 2024. Unaudited financial results as at 30th June 2024.
BSE 30-Jul-2024	Intimation FILE	Board Meeting Intimation for Approval Of Financial Results As On 30Th June 2024. Nath Bio-Genes (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/08/2024 inter alia to consider and approve Unaudited financial results as on 30th June 2024.
BSE 23-Jul-2024	Intimation FILE	Record Date Record date for AGM and Dividend is Friday 09th August 2024
BSE 23-Jul-2024	General Announcements FILE	Reg. 34 (1) Annual Report. Annual Report for the financial year 2023-24
BSE 23-Jul-2024	General Announcements FILE	Notice Of Annual General Meeting Notice of Annual General Meeting and Annual Report for the financial year 2023-24
BSE 13-Jul-2024	General Announcements FILE	Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Compliance Certificate under Reg 74 (5) of SEBI (DP) Regulation.
BSE 29-Jun-2024	Intimation FILE	Closure of Trading Window Closure of Trading window
BSE 14-Jun-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Reg 39 (3) for Details of Loss of Share Certificate.
BSE 29-May-2024	Compliance FILE	Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance Report for FY 2024.
BSE 28-May-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Compliance under Regulation 39(3) of SEBI LODR Regulations 2015. for details of loss of share certificate by the shareholder of the Company.
BSE 14-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Earnings Call Transcript Earnings Call transcript held on 09th May 2024
BSE 09-May-2024	General Announcements FILE	Audio Recording Of Conference Call Audio Recording of Conference call held on 09th May 2024 at 04:00 PM on Audited Financial Results of the Company.
BSE 09-May-2024	General Announcements FILE	Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Details of Loss of Share Certificate by the Shareholder.
BSE 08-May-2024	General Announcements FILE	Announcement under Regulation 30 (LODR)-Investor Presentation Investor Presentation on Audited Financial Results as on 31st March 2024.

INSIDER TRADING FOR NATH BIO-GENES

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 21-Feb-2024 21-Feb-2024	Buy Inter-Se Transfer	504,000 @ 0.00 (2.65 %)	AKASH FARMS LLP
BSE 21-Feb-2024 21-Feb-2024	Sell Inter-Se Transfer	504,000 @ 0.00 (0.00 %)	AGRI-TECH INDIA LTD
BSE 15-Dec-2023 15-Dec-2023	Sell Market	311,831 @ 0.00 (1.64 %)	AGRI-TECH INDIA LTD
BSE 15-Dec-2023 15-Dec-2023	Buy Market	311,831 @ 0.00 (1.64 %)	AKASH FARMS LLP
BSE 08-Dec-2023 08-Dec-2023	Buy Inter-Se Transfer	510,500 @ 0.00 (2.69 %)	ASHU FARMS LLP
BSE 08-Dec-2023 08-Dec-2023	Sell Inter-Se Transfer	510,500 @ 0.00 (2.69 %)	AGRI-TECH INDIA LTD
BSE 24-Aug-2022 24-Aug-2022	Buy Market Purchase	690,000 @ 0.00 (0.00 %)	EMERALD SEEDS PRIVATE LIMITED
BSE 17-Aug-2022 17-Aug-2022	Buy Market Purchase	170,321 @ 0.00 (0.90 %)	AGRI-TECH INDIA LIMITED
BSE 02-Jun-2022 06-Jun-2022	Buy Market	2,798 @ 0.00 (0.01 %)	AGRI-TECH INDIA LTD
BSE 28-Mar-2022 28-Mar-2022	Buy Off Market	100,000 @ 0.00 (0.52 %)	BARKHA FARMS PVT LTD
BSE 21-Mar-2022 25-Mar-2022	Buy Market	332,000 @ 0.00 (1.75 %)	NATH INDUSTRIES LTD
BSE 21-Mar-2022 25-Mar-2022	Sell Market	332,000 @ 0.00 (1.75 %)	AKASH FARMS LLP
BSE 30-Nov-2021 30-Nov-2021	Buy Off Market	100,000 @ 0.00 (0.53 %)	AGRI-TECH INDIA LTD
BSE 28-Mar-2022 28-Mar-2022	Sell Off Market	100,000 @ 0.00 (0.52 %)	AGRI-TECH INDIA LTD
BSE 30-Nov-2021 30-Nov-2021	Sell Off Market	100,000 @ 0.00 (0.52 %)	BARKHA FARMS PVT LTD
BSE 22-Mar-2022 22-Mar-2022	Buy Market	26,346 @ 0.00 (0.03 %)	AGRI-TECH INDIA LTD
BSE 23-Mar-2022 23-Mar-2022	Buy Market	2,745 @ 0.00 (0.00 %)	AGRI-TECH INDIA LTD
BSE 30-Nov-2021 06-Dec-2021	Buy Market	45,000 @ 0.00 (0.23 %)	NATH INDURSTRIES LTD
BSE 30-Nov-2021 06-Dec-2021	Sell Market	45,000 @ 0.00 (0.23 %)	AKASH FARMS LLP
BSE 30-Nov-2021 04-Dec-2021	Sell Market	25,000 @ 0.00 (0.13 %)	AKASH FARMS LLP
BSE 30-Nov-2021 04-Dec-2021	Buy Market	25,000 @ 0.00 (0.14 %)	NATH INDURSTRIES LTD
BSE 22-Nov-2021 26-Nov-2021	Sell Market	50,000 @ 0.00 (0.27 %)	AKASH FARMS LLP
BSE 22-Nov-2021 26-Nov-2021	Buy Market	50,000 @ 0.00 (0.26 %)	NATH INDURSTRIES LTD
BSE 12-Nov-2021 18-Nov-2021	Sell Market	80,000 @ 0.00 (0.42 %)	AKASH FARMS LLP
BSE 12-Nov-2021 18-Nov-2021	Buy Market	80,000 @ 0.00 (0.00 %)	NATH INDURSTRIES Ltd

BULK BLOCK DEALS FOR NATH BIO-GENES (INDIA) LIMITED

Exchange Dates	Activity	Qty & Price (%)	Person / Organisation
BSE 21-Feb-2024	Sell BULK	504,000 @ 217.00	AGRI TECH INDIA LIMITED
BSE 21-Feb-2024	Buy BULK	504,000 @ 217.00	AKASH FARMS LLP
BSE 21-Feb-2024	Sell BLOCK	504,000 @ 217.00	AGRI TECH INDIA LIMITED
BSE 21-Feb-2024	Buy BLOCK	504,000 @ 217.00	AKASH FARMS LLP
BSE 19-Jan-2024	Buy BULK	208,000 @ 229.00	BAKULESH SHAH PRIVATE TRUST
BSE 19-Jan-2024	Sell BULK	208,000 @ 229.00	KBS PROPERTIES PRIVATE LIMITED
BSE 22-Dec-2023	Sell BULK	168,800 @ 211.00	AGRI TECH INDIA LIMITED
BSE 22-Dec-2023	Buy BULK	168,800 @ 211.00	BARKHA FARMS LLP
BSE 15-Dec-2023	Sell BULK	311,831 @ 199.25	AGRI TECH INDIA LIMITED
BSE 15-Dec-2023	Buy BULK	311,831 @ 199.25	AKASH FARMS LLP
BSE 08-Dec-2023	Sell BULK	510,500 @ 196.00	AGRI TECH INDIA LIMITED
BSE 08-Dec-2023	Buy BULK	510,500 @ 196.00	ASHU FARMS LLP
BSE 08-Dec-2023	Sell BLOCK	510,500 @ 196.00	AGRI TECH INDIA LIMITED
BSE 08-Dec-2023	Buy BLOCK	510,500 @ 196.00	ASHU FARMS LLP
BSE 09-Dec-2022	Sell BULK	132,000 @ 180.75	BAKULESH SHAH PRIVATE TRUST
BSE 09-Dec-2022	Buy BULK	132,000 @ 180.75	KBS PROPERTIES PRIVATE LIMITED

DIVIDEND BY NATH BIO-GENES (INDIA) LIMITED

Ex Dividend Date	Dividend Type	Dividend
09-Aug-2024	DIVIDEND	2
04-Jul-2023	DIVIDEND	2
23-Jun-2022	DIVIDEND	2
18-Aug-2021	DIVIDEND	2

SPLIT / BONUS BY NATH BIO-GENES (INDIA) LIMITED

No Split / Bonus details found

Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed

Facebook

Twitter

To TOP

Nath Bio-Genes (India) Limited

Nath Bio-Genes share price

CONSOLIDATED QUARTERLY RESULT FOR NATH BIO-GENES (INDIA) LIMITED

STANDALONE QUARTERLY RESULT FOR NATH BIO-GENES (INDIA) LIMITED

CONSOLIDATED ANNUAL RESULT FOR NATH BIO-GENES (INDIA) LIMITED

STANDALONE ANNUAL RESULT FOR NATH BIO-GENES (INDIA) LIMITED

CONSOLIDATED PROFIT / LOSS FOR NATH BIO-GENES (INDIA) LIMITED

STANDALONE PROFIT / LOSS FOR NATH BIO-GENES (INDIA) LIMITED

CONSOLIDATED CASH FLOW FOR NATH BIO-GENES (INDIA) LIMITED

STANDALONE CASH FLOW FOR NATH BIO-GENES (INDIA) LIMITED

CONSOLIDATED BALANCE SHEET FOR NATH BIO-GENES (INDIA) LIMITED

STANDALONE BALANCE SHEET FOR NATH BIO-GENES (INDIA) LIMITED

FINANCIAL RATIOS (CONSOLIDATED) FOR NATH BIO-GENES (INDIA) LIMITED

FINANCIAL RATIOS (STANDALONE) FOR NATH BIO-GENES (INDIA) LIMITED

SHARE HOLDING PATTERN FOR NATH BIO-GENES (INDIA) LIMITED

PEER COMPARISON FOR NATH BIO-GENES (INDIA) LIMITED

CORPORATE ACTIONS FOR NATH BIO-GENES

CORPORATE ANNOUNCEMENTS FOR NATH BIO-GENES

INSIDER TRADING FOR NATH BIO-GENES

BULK BLOCK DEALS FOR NATH BIO-GENES (INDIA) LIMITED

DIVIDEND BY NATH BIO-GENES (INDIA) LIMITED

SPLIT / BONUS BY NATH BIO-GENES (INDIA) LIMITED